Home/Filings/4/0001408408-18-000014
4//SEC Filing

Eastern Capital LTD 4

Accession 0001408408-18-000014

CIK 0001420720other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 6:03 PM ET

Size

11.4 KB

Accession

0001408408-18-000014

Insider Transaction Report

Form 4
Period: 2018-06-26
Transactions
  • Purchase

    Common Shares

    2018-06-26$0.90/sh+1,683,334$1,515,0016,257,734 total
  • Purchase

    Series B Preferred Shares

    2018-06-26$1000.00/sh+5,785$5,785,0005,785 total
    Common Stock (6,427,778 underlying)
Transactions
  • Purchase

    Series B Preferred Shares

    2018-06-26$1000.00/sh+5,785$5,785,0005,785 total
    Common Stock (6,427,778 underlying)
  • Purchase

    Common Shares

    2018-06-26$0.90/sh+1,683,334$1,515,0016,257,734 total
Transactions
  • Purchase

    Series B Preferred Shares

    2018-06-26$1000.00/sh+5,785$5,785,0005,785 total
    Common Stock (6,427,778 underlying)
  • Purchase

    Common Shares

    2018-06-26$0.90/sh+1,683,334$1,515,0016,257,734 total
Footnotes (2)
  • [F1]Eastern Capital Limited acquired 1,683,334 shares of Common Stock of the Issuer (the "Shares") at a price of $0.90 per share and 5,785 Series B Preferred Shares at an offering price of $1,000 per Series B Preferred Share on June 26, 2018, in an underwritten public offering.
  • [F2]The Series B Preferred Shares is convertible into Shares at the option of Eastern Capital Limited, at any time, at a conversion price equal to the public offering price of the Shares, and are subject to a limit of exercise to the extent (and only to the extent) that Eastern Capital Limited or any of its affiliates would beneficially own in excess of 48% of the Shares after giving effect to such exercise.

Issuer

iBio, Inc.

CIK 0001420720

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001408408

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 6:03 PM ET
Size
11.4 KB